OIG To CMS: Collect Data, Probe MA Post-Acute Care Denials

Why It Matters

If MA plans are found to be denying appropriate post‑acute care, beneficiaries could face gaps in treatment and regulators may impose stricter oversight, reshaping the MA market.

Key Takeaways

• Largest three Medicare Advantage insurers led post‑acute care denial rates June 2024
• OIG alleges MA plans may not match traditional Medicare benefits
• CMS directed to gather detailed denial data and launch a probe
• Potential policy revisions could tighten oversight of MA post‑acute services

Pulse Analysis

Medicare Advantage has become the dominant enrollment option for millions of seniors, promising to mirror traditional Medicare’s coverage while offering additional network benefits. A critical component of that promise is access to post‑acute care—rehabilitation, skilled nursing, and home health services that bridge hospital stays to full recovery. As MA enrollment climbs, regulators watch closely to ensure that cost‑containment strategies do not erode the quality or availability of these essential services.

In June 2024, the Office of Inspector General released a report highlighting that the three largest MA organizations posted the highest denial rates for specific post‑acute care categories. The OIG flagged inconsistencies between the plans’ advertised benefit parity and actual claim outcomes, suggesting that beneficiaries may be left without needed care. By requesting CMS to compile granular denial data and launch a formal investigation, the OIG aims to uncover whether systemic issues, such as overly restrictive medical necessity criteria or administrative bottlenecks, are driving the denials.

The implications extend beyond individual patients. Should CMS confirm widespread non‑compliance, it could introduce tighter reporting requirements, adjust reimbursement formulas, or impose penalties on non‑conforming plans. Industry stakeholders anticipate that heightened oversight may prompt MA carriers to revise utilization management policies and invest in better care coordination. For providers and beneficiaries alike, the outcome will shape the balance between cost efficiency and the delivery of comprehensive, timely post‑acute care.